Use of a plasminogen activator for the treatment of pulmonary disorders

摘要

A new use of a plasminogen activator for the manufacture of a pharmaceutical composition for pulmonary administration as an aerosol for the treatment of pulmonary disorders caused by or related to the presence of fibrin is disclosed. A device provided with a container containing a liquid solution of a plasminogen activator and means for nebulizing the liquid solution is also disclosed.